Contact Us

GET IN TOUCH

Founded in 2013, Syntimmune is the world’s leader in the biology of the neonatal Fc receptor (FcRn). Helmed by the most recognized experts in its field, Syntimmune is positioned to rapidly advance breakthrough therapies which co-opt this unique target.


Syntimmune

116 Huntington Ave, Suite 301
Boston, MA 02116
USA


[/vc_row